153 related articles for article (PubMed ID: 6477350)
21. Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol.
Youle RJ; Colombatti M
J Biol Chem; 1987 Apr; 262(10):4676-82. PubMed ID: 3558362
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain.
Vallera DA; Quinones RR; Azemove SM; Soderling CC
Transplantation; 1984 Apr; 37(4):387-92. PubMed ID: 6231750
[TBL] [Abstract][Full Text] [Related]
23. Cell-specific cytotoxicity expressed by a conjugate of ricin and murine monoclonal antibody directed against thy 1.1 antigen.
Houston LL; Nowinski RC
Cancer Res; 1981 Oct; 41(10):3913-7. PubMed ID: 6116537
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
25. Cell surface and intracellular functions for ricin galactose binding.
Newton DL; Wales R; Richardson PT; Walbridge S; Saxena SK; Ackerman EJ; Roberts LM; Lord JM; Youle RJ
J Biol Chem; 1992 Jun; 267(17):11917-22. PubMed ID: 1601861
[TBL] [Abstract][Full Text] [Related]
26. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
Takahashi T; Seto M; Hara T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
[TBL] [Abstract][Full Text] [Related]
27. Toxicity of a monoclonal F(ab')2:ricin A conjugate for retinoblastoma in vitro.
Merriam JC; Lyon HS; Char DH
Cancer Res; 1984 Aug; 44(8):3178-83. PubMed ID: 6744258
[TBL] [Abstract][Full Text] [Related]
28. Cell targeting of a pore-forming toxin, CytA delta-endotoxin from Bacillus thuringiensis subspecies israelensis, by conjugating CytA with anti-Thy 1 monoclonal antibodies and insulin.
al-yahyaee SA; Ellar DJ
Bioconjug Chem; 1996; 7(4):451-60. PubMed ID: 8853459
[TBL] [Abstract][Full Text] [Related]
29. Novel chimeric anti-ricin antibody C4C13 with neutralizing activity against ricin toxicity.
Wang Y; Guo L; Zhao K; Chen J; Feng J; Sun Y; Li Y; Shen B
Biotechnol Lett; 2007 Dec; 29(12):1811-6. PubMed ID: 17657413
[TBL] [Abstract][Full Text] [Related]
30. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
Seon BK
Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
[TBL] [Abstract][Full Text] [Related]
31. Preparation of concanavalin A-ricin A-chain conjugate and its biologic activity against various cultured cells.
Yamaguchi T; Kato R; Beppu M; Terao T; Inoue Y; Ikawa Y; Osawa T
J Natl Cancer Inst; 1979 Jun; 62(6):1387-95. PubMed ID: 286111
[TBL] [Abstract][Full Text] [Related]
32. Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats.
Worrell NR; Cumber AJ; Parnell GD; Mirza A; Forrester JA; Ross WC
Anticancer Drug Des; 1986 Nov; 1(3):179-88. PubMed ID: 3502450
[TBL] [Abstract][Full Text] [Related]
33. The role of binding ligand in toxic hybrid proteins: a comparison of EGF-ricin, EGF-ricin A-chain, and ricin.
Herschman HR
Biochem Biophys Res Commun; 1984 Oct; 124(2):551-7. PubMed ID: 6333873
[TBL] [Abstract][Full Text] [Related]
34. Milk matrix effects on antibody binding analyzed by enzyme-linked immunosorbent assay and biolayer interferometry.
Brandon DL; Adams LM
J Agric Food Chem; 2015 Apr; 63(13):3593-8. PubMed ID: 25822824
[TBL] [Abstract][Full Text] [Related]
35. Insulin-ricin B chain conjugate has enhanced biological activity in insulin-insensitive cells.
Roth RA; Iwamoto Y; Maddux B; Goldfine ID
Endocrinology; 1983 Jun; 112(6):2193-9. PubMed ID: 6343061
[TBL] [Abstract][Full Text] [Related]
36. Modification of the binding site(s) of lectins by an affinity column carrying an activated galactose-terminated ligand.
Moroney SE; D'Alarcao LJ; Goldmacher VS; Lambert JM; Blättler WA
Biochemistry; 1987 Dec; 26(25):8390-8. PubMed ID: 3442663
[TBL] [Abstract][Full Text] [Related]
37. [Interaction between ricin and Zajdela ascitic hepatoma cells].
Decastel M; Haentjens G; Aubery M; Goussault Y
C R Acad Sci III; 1988; 307(4):165-70. PubMed ID: 3144418
[TBL] [Abstract][Full Text] [Related]
38. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
39. Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells.
Raso V; Griffin T
Cancer Res; 1981 Jun; 41(6):2073-8. PubMed ID: 7237414
[TBL] [Abstract][Full Text] [Related]
40. The binding of ricin to its receptor is not required for the expression of its toxicity.
Morino H; Sakakibara R; Ishiguro M
Biol Pharm Bull; 1995 Dec; 18(12):1770-2. PubMed ID: 8787805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
